4.7 Article

Combination of mulberry leaf active components possessed synergetic effect on SD rats with diabetic nephropathy by mediating metabolism, Wnt/β-catenin and TGF-β/Smads signaling pathway

Journal

JOURNAL OF ETHNOPHARMACOLOGY
Volume 292, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2022.115026

Keywords

Mulberry leaf; Diabetic nephropathy; Network pharmacology; Metabolomics; Synergistic effect

Funding

  1. Zhejiang Province Public Welfare Technology Application Project of China [LGF19H280007, LGN22H280009]
  2. Science and technology plan project of Zhejiang drug supervision system [2022008]
  3. Ningbo Natural Science Foundation Project [2018A610428, 2018A610431]
  4. Ningbo public welfare plan project [202002N3142]
  5. Open research project of Hainan Key Labora-tory of tropical medicinal plant research and development [KF201802]

Ask authors/readers for more resources

This study investigated the protective and synergistic effect of a combination of mulberry leaf alkaloids and flavonoids extract on diabetic nephropathy (DN). The results showed that these compounds had anti-DN activity and could regulate various metabolic pathways. MAF(1:1) and MAF(1:5) had superior therapeutic effects compared to the single use of MA or MF, indicating a synergistic effect. These findings are scientifically significant and valuable for understanding the benefits of mulberry leaf in preventing and treating DN.
Ethnopharmacological relevance: Mulberry leaf has attracted much attention due to its excellent curative effect on diabetes and its complications, whether the combination of its effective components have protective and synergistic effect on diabetic nephropathy (DN) in vivo remain unclear. Aim of the study: The aim of this study was to investigate the protective and synergistic effect of the combination (MAF(1:1) and MAF(1:5)) of mulberry leaf alkaloids (MA) and flavonoids extract (MF) on DN. Materials and methods: A step by step method consisted of network pharmacological prediction, animal in vivo validation and metabolic mechanism research was used to construct the multi-component-target-pathway network of mulberry leaf against DN. Firstly, the potential components and mechanism of mulberry leaf against DN was explored by network pharmacology analysis. Secondly, DN animal model was established to validate the anti-DN activity of these potential compounds. Thirdly, the metabolomics of serum and urine samples from animal experiments was analyzed to explore the anti-DN mechanism of these potential compounds. Results: The results of network pharmacology demonstrated that a total of 7 compounds detected in MA and MF exhibited anti-DN activity, their mechanism were strongly in connection with metabolic pathways, arachidonic acid metabolism, sphingolipid signaling pathway, etc. The results of animal experiment indicated that MAF(1:1) and MAF(1:5) significantly relieved metabolic disorders through regulating Wnt/beta-catenin and TGF-beta/Smads signaling pathway, just like MF or MA alone. Metabolomics suggested they could regulate 16 serum and 7 urine endogenous metabolites through arachidonic acid metabolism, phenylalanine metabolism and sphingolipid metabolism, thus alleviated DN. Significantly, MAF(1:1 )and MAF(1:5) might possess synergistic effect considering their therapeutic effects on DN rats were superior to the single use of MA or MF. Conclusions: MAF(1:1) and MAF(1:5) possessed protective and synergistic effect on DN rats through multi-target and multi-pathways. These findings were of great scientific significance and application value to reveal the advantage of mulberry leaf in preventing and treating DN.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available